Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Walshe

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 1999
Penicillamine: the treatment of first choice for patients with Wilson's diseaseJ M Walshe
Lancet (London, England)|December 22, 1990
Ethics committeesJ M Walshe
ISRN Neurology|March 6, 2012
Penicillamine neurotoxicity: an hypothesisJ M Walshe
QJM : Monthly Journal of the Association of Physicians|January 24, 2006
Management of rare diseasesJ M Walshe
Lancet (London, England)|March 12, 1977
Wilson's disease and chronic active hepatitisJ M Walshe
QJM : Monthly Journal of the Association of Physicians|July 1, 1996
Treatment of Wilson's disease: the historical backgroundJ M Walshe
Progress in Clinical and Biological Research|January 1, 1979
The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1)J M Walshe
British Medical Journal (Clinical Research Ed.)|September 1, 1984
Treatment of Wilson's disease with zinc sulphateJ M Walshe
Current Treatment Options in Gastroenterology|November 30, 2005
Hepatic Wilson's disease: initial treatment and long-term managementJ M Walshe
Lancet (London, England)|March 21, 2007
Wilson's diseaseJ M Walshe
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 1999
Penicillamine: the treatment of first choice for patients with Wilson's diseaseJ M Walshe
Lancet (London, England)|December 22, 1990
Ethics committeesJ M Walshe
ISRN Neurology|March 6, 2012
Penicillamine neurotoxicity: an hypothesisJ M Walshe
QJM : Monthly Journal of the Association of Physicians|January 24, 2006
Management of rare diseasesJ M Walshe
Lancet (London, England)|March 12, 1977
Wilson's disease and chronic active hepatitisJ M Walshe
QJM : Monthly Journal of the Association of Physicians|July 1, 1996
Treatment of Wilson's disease: the historical backgroundJ M Walshe
Progress in Clinical and Biological Research|January 1, 1979
The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1)J M Walshe
British Medical Journal (Clinical Research Ed.)|September 1, 1984
Treatment of Wilson's disease with zinc sulphateJ M Walshe
Current Treatment Options in Gastroenterology|November 30, 2005
Hepatic Wilson's disease: initial treatment and long-term managementJ M Walshe
Lancet (London, England)|March 21, 2007
Wilson's diseaseJ M Walshe
Pageof 11